Man Group’s Journey Medical DERM Stock Holding History

Man Group’s Portfolio DERM Stock Details DERM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-18,268	Closed	-$105K	–	2146
2023 Q4	$105K	Buy	+18,268	New	+$81.4K	﹤0.01%	1977

Other funds holding DERM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

AFG

American Financial Group Cincinnati, Ohio $270M AUM 3.25% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Man Group's DERM Position: Q1 2024 in Review

Man Group sold out of Journey Medical (DERM) in Q1 2024, closing a stake of 18,268 shares — an estimated $105K sold.

Man Group first reported a position in DERM in Q4 2023 and held it in 1 quarter. The position peaked at $105K in Q4 2023. 33 funds tracked by Wall St. Rank hold DERM as of Q1 2024.

Man Group reported no remaining Journey Medical position as of Q1 2024 after selling out during the quarter.
Man Group sold 18,268 Journey Medical shares in Q1 2024, an estimated $105K.
Man Group first reported a position in Journey Medical in Q4 2023 and held it in 1 quarter.
Man Group's Journey Medical position peaked at $105K in Q4 2023.
33 funds tracked by Wall St. Rank held Journey Medical as of Q1 2024.

Based on Man Group's 13F filing for Q1 2024, filed 15 May 2024.